'Corrigendum to "Control of host inflammatory responsiveness by indigenous microbiota reveals an adaptive component of the innate immune system" [Microbes Infect 13 (2011) 1121-32]' DOI: 10.1016/j.micinf.2011.07.012;Control of host inflammatory responsiveness by indigenous microbiota reveals an adaptive component of the innate immune system

Microbes and Infection

Volumn 13, Issue 14-15, 2011, Pages 1121-1132

  Fagundes, Caio T ^a   Souza, Danielle G ^a   Nicoli, Jacques R ^a   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Infection; Inflammation; Innate immunity; Microbiota

Indexed keywords

ANNEXIN; ANTIBIOTIC AGENT; INTERLEUKIN 10; LIPOXIN A; PREBIOTIC AGENT; PROBIOTIC AGENT;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; BACILLI; BACTEROIDETES; BIFIDOBACTERIACEAE; DEPLETION; DIET; ENTEROCOCCUS FAECALIS; EXPERIMENTAL STUDY; GASTROINTESTINAL TRACT; GERMFREE ANIMAL; GNOTOBIOTICS; HOST; HOST INFLAMMATORY RESPONSIVENESS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; MICROBIAL COLONIZATION; MICROFLORA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REPERFUSION INJURY; SHORT SURVEY; SYMBIOSIS;

EID: 81155149967     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.08.019     Document Type: Erratum

References (70)

1. Ley R.E., Peterson D.A., Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848.
2. Billroth T. Untersuchungen über die Vegetationsformen von Coccobacteria septic 1874, Berlin.
3. Escherich T. Die Darmbakterien des Neugeborenen und Säuglings. Fortschritte der Medizin 1885, 3:515-547.
4. Adlerberth I., Wold A.E. Establishment of the gut microbiota in Western infants. Acta Paediatr. 2009, 98:229-238.
5. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
6. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
7. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
8. Ley R.E., Lozupone C.A., Hamady M., Knight R., Gordon J.I. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat. Rev. Microbiol. 2008, 6:776-788.
9. Weaver G.A., Krause J.A., Miller T.L., Wolin M.J. Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulosis. Gut 1986, 27:698-704.
10. Candida and candidiasis 2001, ASM Press, Washington, D.C. R.A. Calderone (Ed.).
11. Swidsinski A., Weber J., Loening-Baucke V., Hale L.P., Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol. 2005, 43:3380-3389.
12. Momose Y., Hirayama K., Itoh K. Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7. Antonie Van Leeuwenhoek 2008, 94:165-171.
13. Servin A.L., Coconnier M.H. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract. Res. Clin. Gastroenterol. 2003, 17:741-754.
14. Servin A.L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 2004, 28:405-440.
15. Czerucka D., Roux I., Rampal P. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells. Gastroenterol. 1994, 106:65-72.
16. Brandao R.L., Castro I.M., Bambirra E.A., Amaral S.C., Fietto L.G., Tropia M.J., Neves M.J., Dos Santos R.G., Gomes N.C., Nicoli J.R. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl. Environ. Microbiol. 1998, 64:564-568.
17. Sonnenburg J.L., Xu J., Leip D.D., Chen C.H., Westover B.P., Weatherford J., Buhler J.D., Gordon J.I. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005, 307:1955-1959.
18. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., Mende D.R., Li J., Xu J., Li S., Li D., Cao J., Wang B., Liang H., Zheng H., Xie Y., Tap J., Lepage P., Bertalan M., Batto J.M., Hansen T., Le Paslier D., Linneberg A., Nielsen H.B., Pelletier E., Renault P., Sicheritz-Ponten T., Turner K., Zhu H., Yu C., Jian M., Zhou Y., Li Y., Zhang X., Qin N., Yang H., Wang J., Brunak S., Dore J., Guarner F., Kristiansen K., Pedersen O., Parkhill J., Weissenbach J., Bork P., Ehrlich S.D. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
19. Gustafsson B.E. Vitamin K deficiency in germfree rats. Ann. N. Y. Acad. Sci. 1959, 78:166-174.
20. Wostmann B.S., Larkin C., Moriarty A., Bruckner-Kardoss E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab. Anim. Sci. 1983, 33:46-50.
21. Abrams G.D., Bauer H., Sprinz H. Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice, Lab. Invest 1963, 12:355-364.
22. Smith K., McCoy K.D., Macpherson A.J. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 2007, 19:59-69.
23. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 2010, 10:159-169.
24. Vaishnava S., Behrendt C.L., Ismail A.S., Eckmann L., Hooper L.V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. U. S. A 2008, 105:20858-20863.
25. Eberl G., Lochner M. The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal Immunol. 2009, 2:478-485.
26. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9:313-323.
27. Klare I., Werner G., Witte W. Enterococci. Habitats, infections, virulence factors, resistances to antibiotics, transfer of resistance determinants. Contrib. Microbiol. 2001, 8:108-122.
28. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A 2007, 104:13780-13785.
29. Wu H.J., Ivanov J., Darce K., Hattori T., Shima Y., Umesaki D.R., Littman C., Benoist D. Mathis, Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
30. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007, 7:379-390.
31. Schaedler R.W., Dubs R., Costello R. Association of germfree mice with bacteria isolated from normal mice. J. Exp. Med. 1965, 122:77-82.
32. Dubos R.J., Schaedler R.W. The effect of the intestinal flora on the growth rate of mice, and on their susceptibility to experimental infections. J. Exp. Med. 1960, 111:407-417.
33. Dewhirst F.E., Chien C.C., Paster B.J., Ericson R.L., Orcutt R.P., Schauer D.B., Fox J.G. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl. Environ. Microbiol. 1999, 65:3287-3292.
34. Baker D.G. Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin. Microbiol. Rev. 1998, 11:231-266.
35. Hapfelmeier S., Lawson M.A., Slack E., Kirundi J.K., Stoel M., Heikenwalder M., Cahenzli J., Velykoredko Y., Balmer M.L., Endt K., Geuking M.B., Curtiss R., McCoy K.D., Macpherson A.J. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010, 328:1705-1709.
36. Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007, 1:56-66.
37. Reikvam D.H., Erofeev A., Sandvik A., Grcic V., Jahnsen F.L., Gaustad P., McCoy K.D., Macpherson A.J., Meza-Zepeda L.A., Johansen F.E. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One 2011, 6:e17996.
38. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008, 6:e280.
39. Antonopoulos D.A., Huse S.M., Morrison H.G., Schmidt T.M., Sogin M.L., Young V.B. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 2009, 77:2367-2375.
40. van Ogtrop M.L., Guiot H.F., Mattie H., van Furth R. Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 1991, 35:976-982.
41. Fagarasan S., Muramatsu M., Suzuki K., Nagaoka H., Hiai H., Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002, 298:1424-1427.
42. Clarke T.B., Davis K.M., Lysenko E.S., Zhou A.Y., Yu Y., Weiser J.N. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010, 16:228-231.
43. Willing B.P., Russell S.L., Finlay B.B. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 2011, 9:233-243.
44. Noverr M.C., Huffnagle G.B. Does the microbiota regulate immune responses outside the gut?. Trends Microbiol. 2004, 12:562-568.
45. Dubos R., Schaedler R.W., Stephens M. The effect of antibacterial drugs on the fecal flora of mice. J. Exp. Med. 1963, 117:231-243.
46. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1. 6ra14.
47. Guidelines for the Evaluation of Probiotics in Food, Food and Agriculture Organization of the United Nations & World Health Organization Working Group Report 2002, Food and Agriculture Organization of the United Nations/World Health Organization, London.
48. Alm J.S., Swartz J., Lilja G., Scheynius A., Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999, 353:1485-1488.
49. Tannock G.W., Munro K., Harmsen H.J., Welling G.W., Smart J., Gopal P.K. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 2000, 66:2578-2588.
50. Souza D.G., Vieira A.T., Soares A.C., Pinho V., Nicoli J.R., Vieira L.Q., Teixeira M.M. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J. Immunol. 2004, 173:4137-4146.
51. Granger D.N. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcircul. 1999, 6:167-178.
52. Souza D.G., Teixeira M.M. The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion. Mem. Inst. Oswaldo Cruz 2005, 100(Suppl 1):59-66.
53. Amaral F.A., Sachs D., Costa V.V., Fagundes C.T., Cisalpino D., Cunha T.M., Ferreira S.H., Cunha F.Q., Silva T.A., Nicoli J.R., Vieira L.Q., Souza D.G., Teixeira M.M. Commensal microbiota is fundamental for the development of inflammatory pain. Proc. Natl. Acad. Sci. U. S. A 2008, 105:2193-2197.
54. Martin H.A., Basbaum A.I., Kwiat G.C., Goetzl E.J., Levine J.D. Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs. Neurosci. 1987, 22:651-659.
55. Verri W.A., Cunha T.M., Parada C.A., Poole S., Cunha F.Q., Ferreira S.H. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?. Pharmacol. Ther. 2006, 112:116-138.
56. Oliveira M.R., Tafuri W.L., Afonso L.C., Oliveira M.A., Nicoli J.R., Vieira E.C., Scott P., Melo M.N., Vieira L.Q. Germ-free mice produce high levels of interferon-gamma in response to infection with Leishmania major but fail to heal lesions. Parasitology 2005, 131:477-488.
57. Duarte R., Silva A.M., Vieira L.Q., Afonso L.C., Nicoli J.R. Trypanosoma cruzi: influence of predominant bacteria from indigenous digestive microbiota on experimental infection in mice. Exp. Parasitol. 2005, 111:87-96.
58. Mehrad B., Standiford T.J. Role of cytokines in pulmonary antimicrobial host defense. Immunol. Res. 1999, 20:15-27.
59. dos Santos L.M., Santos M.M., de Souza Silva H.P., Arantes R.M., Nicoli J.R., Vieira L.Q. Monoassociation with probiotic Lactobacillus delbrueckii UFV-H2b20 stimulates the immune system and protects germfree mice against Listeria monocytogenes infection. Med. Microbiol. Immunol. 2011, 200:29-38.
60. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., Schilter H.C., Rolph M.S., Mackay F., Artis D., Xavier R.J., Teixeira M.M., Mackay C.R. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
61. Souza D.G., Fagundes C.T., Amaral F.A., Cisalpino D., Sousa L.P., Vieira A.T., Pinho V., Nicoli J.R., Vieira L.Q., Fierro I.M., Teixeira M.M. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J. Immunol. 2007, 179:8533-8543.
62. Serhan C.N. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?. Am. J. Pathol. 2010, 177:1576-1591.
63. Perretti M., D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 2009, 9:62-70.
64. Angelone D.F., Wessels M.R., Coughlin M., Suter E.E., Valentini P., Kalish L.A., Levy O. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr. Res. 2006, 60:205-209.
65. La Pine T.R., Joyner J.L., Augustine N.H., Kwak S.D., Hill H.R. Defective production of IL-18 and IL-12 by cord blood mononuclear cells influences the T helper-1 interferon gamma response to group B Streptococci. Pediatr. Res. 2003, 54:276-281.
66. Wynn J.L., Scumpia P.O., Winfield R.D., Delano M.J., Kelly-Scumpia K., Barker T., Ungaro R., Levy O., Moldawer L.L. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008, 112:1750-1758.
67. Zhang X., Deriaud E., Jiao X., Braun D., Leclerc C., Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J. Exp. Med. 2007, 204:1107-1118.
68. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
69. Heijtz R.D., Wang S., Anuar F., Qian Y., Bjorkholm B., Samuelsson A., Hibberd M.L., Forssberg H., Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U. S. A 2011, 108:3047-3052.
70. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 2010, 108(Suppl 1):4615-4622.